164 related articles for article (PubMed ID: 10051158)
1. Acute troglitazone action in isolated perfused rat liver.
Preininger K; Stingl H; Englisch R; Fürnsinn C; Graf J; Waldhäusl W; Roden M
Br J Pharmacol; 1999 Jan; 126(1):372-8. PubMed ID: 10051158
[TBL] [Abstract][Full Text] [Related]
2. Effect of troglitazone (Rezulin) on fructose 2,6-bisphosphate concentration and glucose metabolism in isolated rat hepatocytes.
Raman P; Foster SE; Stokes MC; Strenge JK; Judd RL
Life Sci; 1998; 62(8):PL89-94. PubMed ID: 9489515
[TBL] [Abstract][Full Text] [Related]
3. Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis.
Raman P; Judd RL
Eur J Pharmacol; 2000 Dec; 409(1):19-29. PubMed ID: 11099696
[TBL] [Abstract][Full Text] [Related]
4. Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro.
Fürnsinn C; Neschen S; Noe C; Bisschop M; Roden M; Vogl C; Schneider B; Waldhäusl W
Br J Pharmacol; 1997 Dec; 122(7):1367-74. PubMed ID: 9421284
[TBL] [Abstract][Full Text] [Related]
5. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
[TBL] [Abstract][Full Text] [Related]
6. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone directly inhibits CO(2) production from glucose and palmitate in isolated rat skeletal muscle.
Fürnsinn C; Brunmair B; Neschen S; Roden M; Waldhäusl W
J Pharmacol Exp Ther; 2000 May; 293(2):487-93. PubMed ID: 10773019
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.
Bähr M; Spelleken M; Bock M; von Holtey M; Kiehn R; Eckel J
Diabetologia; 1996 Jul; 39(7):766-74. PubMed ID: 8817100
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone enhances glucose uptake induced by alpha-adrenoceptor stimulation via phosphatidylinositol 3-kinase in rat heart.
Yoshioka J; Kusuoka H; Imahashi K; Hashimoto K; Hori M; Terakawa T; Nishimura T
Clin Exp Pharmacol Physiol; 2001 Sep; 28(9):752-7. PubMed ID: 11553036
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone reduces free fatty acid-induced insulin resistance in perfused rat hindquarter.
Mokuda O; Sakamoto Y
Diabetes Metab; 1998 Sep; 24(4):362-4. PubMed ID: 9805648
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats.
Fujiwara T; Ohsawa T; Takahashi S; Ikeda K; Okuno A; Ushiyama S; Matsuda K; Horikoshi H
Life Sci; 1998; 63(22):2039-47. PubMed ID: 9839548
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of troglitazone on in vivo insulin action in normal rats.
Lee MK; Olefsky JM
Metabolism; 1995 Sep; 44(9):1166-9. PubMed ID: 7666790
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
Dea MK; Van Citters GW; Ader M; Mittelman SD; Sunehag AL; Bergman RN
Diabetes; 2000 Dec; 49(12):2087-93. PubMed ID: 11118011
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
Chicco A; Basabe JC; Karabatas L; Ferraris N; Fortino A; Lombardo YB
Metabolism; 2000 Oct; 49(10):1346-51. PubMed ID: 11079827
[TBL] [Abstract][Full Text] [Related]
18. Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats.
Santuré M; Pitre M; Nadeau A; Bachelard H
Metabolism; 2003 Aug; 52(8):978-86. PubMed ID: 12898461
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts.
Shimoyama M; Ogino K; Tanaka Y; Ikeda T; Hisatome I
Diabetes; 1999 Mar; 48(3):609-15. PubMed ID: 10078564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
